about
Glycosylation of glycolipids in cancer: basis for development of novel therapeutic approachesCeramide-induced apoptosis in renal tubular cells: a role of mitochondria and sphingosine-1-phoshateGanglioside GM1 induces phosphorylation of mutant huntingtin and restores normal motor behavior in Huntington disease miceAn introduction to sphingolipid metabolism and analysis by new technologiesMultiple phenotypic changes in mice after knockout of the B3gnt5 gene, encoding Lc3 synthase--a key enzyme in lacto-neolacto ganglioside synthesisNeutral glycosphingolipids in human blood: a precise mass spectrometry analysis with special reference to lipoprotein-associated Shiga toxin receptorsCritical role for the protons in FRTL-5 thyroid cells: nuclear sphingomyelinase induced-damage.Sphingolipid and glycosphingolipid metabolic pathways in the era of sphingolipidomics.Acid ceramidase (ASAH1) is a global regulator of steroidogenic capacity and adrenocortical gene expressionIt's a lipid's world: bioactive lipid metabolism and signaling in neural stem cell differentiation.C6 pyridinium ceramide influences alternative pre-mRNA splicing by inhibiting protein phosphatase-1.Acid ceramidase (ASAH1) represses steroidogenic factor 1-dependent gene transcription in H295R human adrenocortical cells by binding to the receptor.Ceramide signaling in cancer and stem cells.The Protective Effect of Gangliosides on Lead (Pb)-Induced Neurotoxicity Is Mediated by Autophagic Pathways.APOE polymorphisms influence longitudinal lipid trends preceding intracerebral hemorrhageDirect interaction between the inhibitor 2 and ceramide via sphingolipid-protein binding is involved in the regulation of protein phosphatase 2A activity and signalingFunctional roles of gangliosides in neurodevelopment: an overview of recent advances.Glucocerebroside: an evolutionary advantage for patients with Gaucher disease and a new immunomodulatory agent.An inducible ER-Golgi tether facilitates ceramide transport to alleviate lipotoxicityLipid mediators in the neural cell nucleus: their metabolism, signaling, and association with neurological disorders.Sphingolipids and gangliosides of the nervous system in membrane function and dysfunction.The interplay between bioactive sphingolipids and steroid hormones.Sphingolipids and cancer: ceramide and sphingosine-1-phosphate in the regulation of cell death and drug resistance.Stem cell glycolipids.Nuclear sphingolipid metabolism.Structures, biosynthesis, and functions of gangliosides--an overview.The role of gangliosides in neurodevelopment.Role of sphingomyelinases in neurological disorders.Dissecting the Role of Anti-ganglioside Antibodies in Guillain-Barré Syndrome: an Animal Model Approach.Nuclear Drosophila CerS Schlank regulates lipid homeostasis via the homeodomain, independent of the lag1p motif.Lipid remodelling in human melanoma cells in response to UVA exposure.Nuclear Lipids in the Nervous System: What they do in Health and Disease.Profiling changes triggered during maturation of dendritic cells: a lipidomic approach.Intranuclear membranes induced by lipidated proteins are derived from the nuclear envelope.Nuclear Lipid Mediators: Role of Nuclear Sphingolipids and Sphinosine-1-Phosphate Signaling in Epigenetic Regulation of Inflammation and Gene Expression.Anandamide Revisited: How Cholesterol and Ceramides Control Receptor-Dependent and Receptor-Independent Signal Transmission Pathways of a Lipid Neurotransmitter.MetabolismStructure and Dynamics of Glycosphingolipids in Lipid Bilayers: Insights from Molecular Dynamics Simulations
P2860
Q21129299-F49B18B0-2A4B-45DB-9755-13EBCF5634EFQ26822419-232F5F49-6571-49CC-8FF1-62197B59C885Q30506469-0885896F-EDCA-4FD5-8AD6-7ABAA493AA42Q33648081-73F1240B-FB41-45E3-8F04-FF04B008ACAFQ33750767-4657B24B-ED37-490E-8E8A-C413C80BE88DQ33993186-B6A6CAED-764A-49DE-A804-054F9F2F5600Q34072231-E9BBBBFD-AB19-4E92-9BBD-C048825F1632Q35324757-DBD181EF-5A19-4DEA-A0F2-523B5BF679C1Q35744011-BC399842-D73E-44A9-A3C5-6155BB280476Q35931476-7673FBFD-5295-4315-ADF2-C2DF3838BB6AQ35955993-C3056B3E-0F06-4690-B96B-47833425F20FQ36362832-0E0D0CD8-CF59-4FD5-A974-EFFD6CFD1155Q36803735-BE9CC14A-42CA-4EB6-88A3-2622CA3157DFQ36841596-97996C2B-3EC3-40F1-BADF-3818FA0E0527Q37074302-F4E2D241-AD5A-4F37-88B6-68FC28CD8B85Q37123974-6D15356E-7B88-43AA-A41B-FCE7F1BC36B8Q37494316-36ACA3A4-B369-4BDD-AA2F-55F4C171503DQ37520646-499104FC-5980-4428-8584-E05630D920CEQ37576605-BF55088E-37FF-4BD1-8D5E-1302F7943820Q37576857-F95BD14E-0E09-45B1-8605-D96C0D98A5A0Q37652733-98D515A8-BDCF-4797-95B6-16BD4ED1B24FQ37688434-EC1D9F34-5654-4A89-85BB-99B599A46A14Q37808219-D3F8E56C-B490-4DFE-80B2-E8C954551F6DQ37821360-AAB819C7-5295-4D5A-A45C-D35CA25253B1Q37925819-DFB31838-7A74-48C8-B8EA-24A0C3E02141Q37936732-D5C60CDA-4B0B-4B50-AFF7-8AE7ADAF8D94Q38501568-E4BA3B46-183D-466C-AF86-4774A3F4D155Q38560939-FA9D2151-D9B7-4A18-B125-0C38F89D7805Q38587703-5B4F2DFA-EF2B-4730-8A85-6103EE21AB87Q38788263-BED03EC4-371E-4E66-B5AE-F367ADE9A249Q38901714-04B6C3CF-BC05-49EE-83DE-B7F0AA9B8AB3Q38986890-3648D935-4F40-470B-B9B5-5568542723C6Q39382953-F0D7B90C-68BC-49E9-9EA2-5A968A954066Q41846000-A16FE670-90E0-4997-912E-25F45ACBD002Q49610036-21A38E66-17E3-4FE1-8616-1D1CC423801EQ55443804-CCCDED9A-F128-4CB1-99EA-3DF4CF329467Q56336900-84551FD8-61BF-47C8-A77F-6C0802725502Q58655856-AD55F786-67EB-4F8A-9B1A-6310D9E1CFAD
P2860
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Nuclear sphingolipids: metabolism and signaling.
@ast
Nuclear sphingolipids: metabolism and signaling.
@en
type
label
Nuclear sphingolipids: metabolism and signaling.
@ast
Nuclear sphingolipids: metabolism and signaling.
@en
prefLabel
Nuclear sphingolipids: metabolism and signaling.
@ast
Nuclear sphingolipids: metabolism and signaling.
@en
P2860
P1476
Nuclear sphingolipids: metabolism and signaling.
@en
P2093
Gusheng Wu
Robert W Ledeen
P2860
P304
P356
10.1194/JLR.R800009-JLR200
P577
2008-03-09T00:00:00Z